 |
6 Diseases |  |
0 Trials |
|
0 Trials |  |
12 News |  |
- | milategrast (E6007) / Eisai
Trial completion: Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis (clinicaltrials.gov) - Oct 3, 2019
P2, N=147, Completed, Sponsor: EA Pharma Co., Ltd.
Active, not recruiting --> Completed
- | milategrast (E6007) / Eisai
Trial completion date: Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis (clinicaltrials.gov) - Jun 12, 2019
P2, N=147, Active, not recruiting, Sponsor: EA Pharma Co., Ltd.
Active, not recruiting --> Completed Trial completion date: Jun 2019 --> Sep 2019
- || milategrast (E6007) / Eisai
Enrollment closed, Trial completion date: Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis (clinicaltrials.gov) - Mar 11, 2019
P2, N=147, Active, not recruiting, Sponsor: EA Pharma Co., Ltd.
Trial completion date: Jun 2019 --> Sep 2019 Recruiting --> Active, not recruiting | Trial completion date: Mar 2019 --> Jun 2019
- | milategrast (E6007) / Eisai
Trial completion, Trial completion date: A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants (clinicaltrials.gov) - Aug 29, 2018
P1, N=6, Completed, Sponsor: EA Pharma Co., Ltd.
Recruiting --> Active, not recruiting | Trial completion date: Mar 2019 --> Jun 2019 Not yet recruiting --> Completed | Trial completion date: Oct 2018 --> Jun 2018
- | milategrast (E6007) / Eisai
Trial completion date: Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis (clinicaltrials.gov) - Jul 18, 2018
P2, N=144, Recruiting, Sponsor: EA Pharma Co., Ltd.
Not yet recruiting --> Completed | Trial completion date: Oct 2018 --> Jun 2018 Trial completion date: Sep 2019 --> Mar 2019
- milategrast (E6007) / Eisai
New P1 trial: A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants (clinicaltrials.gov) - Feb 23, 2018
P1, N=6, Not yet recruiting, Sponsor: EA Pharma Co., Ltd.
- | milategrast (E6007) / Eisai
New P2 trial: Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis (clinicaltrials.gov) - Jan 11, 2017
P2, N=144, Recruiting, Sponsor: EA Pharma Co., Ltd.
- | milategrast (E6007) / Eisai
Trial completion, Trial primary completion date: Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects (clinicaltrials.gov) - Jan 20, 2016
P1, N=24, Completed, Sponsor: Eisai Co., Ltd.
Trial completion date: Sep 2019 --> Mar 2019 Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jul 2015
- milategrast (E6007) / Eisai
Enrollment closed, Enrollment change: Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects (clinicaltrials.gov) - Mar 12, 2015
P1, N=24, Active, not recruiting, Sponsor: Eisai Co., Ltd.
Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jul 2015 Recruiting --> Active, not recruiting | N=32 --> 24
- milategrast (E6007) / Eisai
Enrollment open: Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects (clinicaltrials.gov) - Dec 17, 2014
P1, N=32, Recruiting, Sponsor: Eisai Co., Ltd.
Recruiting --> Active, not recruiting | N=32 --> 24 Not yet recruiting --> Recruiting
- | milategrast (E6007) / Eisai
New P1 trial: Single/ Multiple-Dose Study of E6007 in Healthy Japanese Male Subjects (clinicaltrials.gov) - Oct 20, 2014
P1, N=32, Not yet recruiting, Sponsor: Eisai Co., Ltd.
- | milategrast (E6007) / Eisai
Trial completion: A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects (clinicaltrials.gov) - Jan 30, 2012
P1, N=48, Completed, Sponsor: Eisai Inc.
Not yet recruiting --> Recruiting Recruiting --> Completed